Ntla stock forecast
The above table shows the analyst NTLA forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$30.65Find the latest Intellia Therapeutics, Inc. (NTLA) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo FinanceStock Price Forecast. The 25 analysts offering 12-month price forecasts for Gilead Sciences Inc have a median target of 90.10, with a high estimate of 116.00 and a low estimate of 71.00. The ...
Did you know?
0.00%. $1.55M. NTLA | Complete Intellia Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Teladoc Health Stock Forecast 11-23-2023. Forecast target price for 11-23-2023: $ 17.85. Positive dynamics for Teladoc Health shares will prevail with possible volatility of 2.410%. Pessimistic target level: 17.63. Optimistic target level: 18.06.Find real-time NKLA - Nikola Corp stock quotes, company profile, news and forecasts from CNN Business.Intellia Therapeutics Inc (NTLA) Stock Price & News - Google Finance Home NTLA • NASDAQ Intellia Therapeutics Inc Follow Share $30.93 After Hours: $31.14 (0.68%) +0.21 Closed: Nov 29, 5:10:43... The latest Intellia Therapeutics stock prices, stock quotes, news, and NTLA history to help you invest and trade smarter. ... The 61 analysts offering price forecasts for Intellia Therapeutics ... Find real-time NTLA - Intellia Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.Find real-time NTLA - Intellia Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.Get the latest Direxion Daily Small Cap Bull 3X ETF (TNA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ...Intellia Therapeutics ( NASDAQ: NTLA) added ~13% on Thursday to reach the highest level in more than two months after the gene-editing company reported its Q1 2023 financials alongside updates ...Find the latest Intellia Therapeutics, Inc. (NTLA) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo FinanceNov 29, 2023 · Complete Intellia Therapeutics Inc. stock information by Barron's. View real-time NTLA stock price and news, along with industry-best analysis. The 24 analysts offering 1 year price forecasts for NTLA have a max estimate of — and a min estimate of —. Analyst rating Based on 27 analysts giving stock ratings to NTLA in …The latest Intellia Therapeutics stock prices, stock quotes, news, and NTLA history to help you invest and trade smarter. ... The 61 analysts offering price forecasts for Intellia Therapeutics ... View the latest Intellia Therapeutics Inc. (NTLA) stock price, news, historical charts, analyst ratings and financial information from WSJ. The 24 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 72.00, with a high estimate of 145.00 and a low estimate of 29.00. The median estimate represents a +137.08% increase from the last price of 30.37. The current consensus among 27 polled investment analysts is to Buy stock in Intellia ...(See NTLA stock forecast on TipRanks) To find good ideas for healthcare stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of ...The European Commission bestows orphan drug designation to Intellia's (NTLA) in vivo CRISPR-based investigational therapy, NTLA-2002, for treating hereditary angioedema. Stock rises. AdvertisementAccording to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.(See NTLA stock forecast on TipRanks) PDS Biotechnology . The next stock on Oppenheimer's radar is another biopharma company, PDS Biotechnology. PDS has a research program focuses on immuno ...Intellia's Q1 2023 financial report shows a cash positioThe average TDOC stock price target stood at $124.77 a share, Find real-time CRSP - CRISPR Therapeutics AG stock quotes, company profile, news and forecasts from CNN Business. Jun 8, 2023 · Here, I discuss the central investing thesis for its NTLA - Free Report) reported second-quarter 2023 loss of $1.40 per share, wider than the Zacks Consensus Estimate of a loss of $1.32. In the year-ago quarter, Intellia incurred a loss of $1.33 per ... Nasdaq provides visual representation of analyst
14,305.03 +78.81(+0.55%) Russell 2000 +53.62(+2.96%) Crude Oil -1.56(-2.05%) Gold 2,091.00 +33.80(+1.64%) Advertisement Intellia Therapeutics, Inc. (NTLA) NasdaqGM - NasdaqGM Real Time Price....Find real-time CRSP - CRISPR Therapeutics AG stock quotes, company profile, news and forecasts from CNN Business.Find the latest Intellia Therapeutics, Inc. NTLA analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating.Nov 29, 2023 · Complete Intellia Therapeutics Inc. stock information by Barron's. View real-time NTLA stock price and news, along with industry-best analysis.
Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...May 4, 2023 · As for financials, the company’s top line and bottom line beat Street forecasts while its cash, cash equivalents, and marketable securities stood at $1.2B at the end of the quarter compared to ... …
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Jul 6, 2023 · Find the latest Intellia Therapeutics, . Possible cause: See Intellia Therapeutics, Inc. (NTLA) stock analyst estimates, including earnin.
Intellia Therapeutics Inc Stock Price History. Intellia Therapeutics Inc’s ( NTLA) price is currently up 15.63% so far this month. During the month of May, Intellia Therapeutics Inc’s stock price has reached a high of $44.21 and a low of $36.89. Over the last year, Intellia Therapeutics Inc has hit prices as high as $76.45 and as low as $32.44.Dec 1, 2023 · 0.00%. $1.55M. NTLA | Complete Intellia Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Intellia Therapeutics ( NASDAQ: NTLA) added ~13% on Thursday to reach the highest level in more than two months after the gene-editing company reported its Q1 2023 financials alongside updates ...
Track Intellia Therapeutics Inc (NTLA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsOct 6, 2020 · For Intellia Therapeutics stock forecast for 2023, 2 predictions are offered for each month of 2023 with average Intellia Therapeutics stock forecast of $23.66, a high forecast of $23.9, and a low forecast of $23.43. The average Intellia Therapeutics stock forecast 2023 represents a 2.17% increase from the last price of $23.1599998474121.
Even after rising 30% so far this year, Complete Intellia Therapeutics Inc. stock information by Barron's. View real-time NTLA stock price and news, along with industry-best analysis.Cathie Wood and Wall Street analysts aren't always on the same page. Analysts are bearish, for example, on the three stocks that have helped the most in Wood's Ark Innovation ETF (ARKK 1.26% ... While NTLA stock may have its naysayers, so far, Wall SCathie Wood and Wall Street analysts aren' NTLA Intellia Therapeutics Inc. 30.85 0.15 ( 0.49%) Market Closed Delayed Prices By NASDAQ, in USD. Trade. Overview Chart Analysis News Stats.Here, I discuss the central investing thesis for its fellow CRISPR/Cas9 gene-editing specialist, Intellia Therapeutics (NTLA 4.08%). This biotech growth stock, too, stands out as a potential ... Earnings vs Market: NTLA is forecast to remain un AAPL. 189.69. -0.01%. 49.41M. View today's Intellia Therapeutics Inc stock price and latest NTLA news and analysis. Create real-time notifications to follow any changes in the live stock price.The 12-month stock price forecast is $69.88, which is an increase of 1.79% from the latest price. Price Target. $69.88 (1.79% upside) Analyst Consensus: Buy. Stock Forecasts. News. All; Videos; Press Press Releases; Conversation; ... Intellia Therapeutics Inc. NTLA, -0.28% shares gained 6.4% premarket on Monday after the clinical stage … 0.00%. $1.55M. NTLA | Complete Intellia Therapeutics Inc. stock About the Roku, Inc. stock forecast. As of 2023 November 30, ThursApr 18, 2023 · Analysts are bullish on NT Intellia was founded in 2014 and went public in 2016, raising net proceeds of $112.1 million at $18 per share. The stock currently trades around $36.00 a share, translating to a market cap of $3. ...NTLA stock forecast for 2023 – 2027. Last updated: November 23, 2023. NTLA. Intellia Therapeutics, Inc. 30.26 D 6.32% (1.80) Are you interested in Intellia Therapeutics, Inc. stocks prediction? Discover historical prices for NTLA stock on Yahoo Finance. Vie Discover historical prices for SAVA stock on Yahoo Finance. View daily, weekly or monthly format back to when Cassava Sciences, Inc. stock was issued. Discover historical prices for NTLA stock on Yahoo Finance. Vi[Find real-time STLA - Stellantis NV stock quotes, co(See NTLA stock forecast)Pacific Bioscie NTLA After-Hours Quotes. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary ...Nov 30, 2023 · According to 2 stock analysts, the average 12-month stock price forecast for DNA stock stock is $1.88, which predicts an increase of 45.74%. The lowest target is $1.25 and the highest is $2.50. On average, analysts rate DNA stock stock as a sell.